Rangarajan Sampath, PhD

Dr. Rangarajan Sampath is a seasoned professional with a career spanning three decades. He is renowned for his visionary leadership and groundbreaking contributions to the fields of medical technologies, in-vitro diagnostics, and digital health solutions. Dr. Sampath’s extensive experience encompasses diverse environments, including start-ups, small and large corporate settings, and the global health sector. As a thought leader in his field, Dr. Sampath continues to be a driving force behind positive change, pushing the boundaries of what is possible in the pursuit of better health and a brighter future for everyone, everywhere.

In his current role as the Senior Vice President and Head of Center for Innovation in Diagnostics at Siemens Healthineers, he leads innovation and new product development in the areas of oncology, neurology and infectious diseases. CID’s focus is to drive disruptive next generation innovation, development and commercialization of in-vitro diagnostics, automation and digital health solutions.

Prior to this, Dr. Sampath was Chief Scientific Officer at Foundation for Innovative New Diagnostics (FIND), a Geneva-based non-profit organization (NGO) focused on bringing cutting edge diagnostics to low- and middle- income countries, where he headed FIND’s research and development organization, leading its innovation, product development and disease programs.

For the first 20+ years of his career Dr. Sampath served as a Volwiler Senior Research Fellow and Senior Director of R&D for the Ibis Division of Abbott. He led Ibis’ R&D efforts in infectious disease diagnostics, antimicrobial resistance diagnostics and surveillance, and was responsible for applications development, validation, data analysis and reporting for the Ibis PCR/ESI-MS based IRIDICA platform. Dr. Sampath was the co-founder of Ibis Biosciences, Inc. and a co-inventor of the IRIDICA (CE-IVD) infectious disease diagnostics platform.

Dr. Sampath is a recognized leader in the field, with over 100 publications and over 40 issued patents in infectious disease diagnostics. He is currently on the Board of Sepsis Alliance, a non-profit dedicated to bringing sepsis awareness to healthcare settings and the general public alike. He has been an invited speaker at many public forums such as at the Institute of Medicine, Infectious Diseases Society of America (IDSA) and Parenteral Drug Association (PDA). Dr. Sampath most recently served for a 3-year term as a member of the Diagnostics Committee for IDSA. His research interests include sepsis, antimicrobial strategy development, pathogen discovery, fevers of unknown origin, tropical diseases, epidemiological surveillance and biothreat detection.

Education
Ph. D., Chemical Engineering, Rice University, Houston, TX
B.S. Chemical Engineering, Indian Institute of Technology, Chennai, India